Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Trevi Therapeutics, Inc. logo — Clinical-stage biopharmaceutical company

Trevi Therapeutics, Inc.

Clinical-stage biopharmaceutical company

Founded 2011 United States New Haven, United States 34 employees Post Ipo Equity Total: $156.53M Biotechnology, Health Care +1

General Information

Company Name Trevi Therapeutics, Inc.
Founded Year 2011
Location United States New Haven, United States +1
Founders / Decision Makers
Team member Team member
Employees 34
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Post Ipo Equity
Social

Get notified when Trevi Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Trevi Therapeutics, Inc.

Trevi Therapeutics is a biotechnology startup founded in 2011. It operates in the healthcare and pharmaceutical industries. Their latest investment of $55.00M in Post-IPO Equity was secured on April 07, 2022. The investment came from a group of prominent investors including New Enterprise Associates, Fairmount Funds, Venrock Healthcare Capital Partners, and Frazier Life Sciences. This recent investment reflects the confidence of these established investors in Trevi Therapeutics' innovative approach and potential for growth.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 4
Investor Investor Investor
•••• •••• 		07 Apr 2022
Series C •••••• 4
Investor Investor Investor
•••• •••• 		01 Jan 2019
Series C •••••• 4
Investor Investor Investor
•••• •••• 		01 Aug 2018
Series C •••••• 5
Investor Investor Investor Investor
•••• •••• 		20 Jul 2017
Debt Financing •••••• 2
Investor
•••• •••• 		08 Jan 2015

View All 7 Funding Rounds

Trevi Therapeutics, Inc. Alternatives & Competitors

Trevi Therapeutics, Inc. vs
Melius Pharma
Melius Pharma Sweden

Clinical stage biopharma company developing treatments for diseases with high unmet needs at a reduc...

Series A
3 employees
Health Care, Pharmaceutical
Compare Trevi Therapeutics, Inc. vs Melius Pharma
Trevi Therapeutics, Inc. vs
NeRRe Therapeutics Ltd
NeRRe Therapeutics Ltd United Kingdom

Developing a breakthrough treatment for the disabling chronic cough associated with idiopathic pulmo...

Series B
9 employees
Biotechnology, Health Care
Compare Trevi Therapeutics, Inc. vs NeRRe Therapeutics Ltd
Trevi Therapeutics, Inc. vs
Hyfe
Hyfe United States

AI-powered cough-tracking & insights. Precision medicine for respiratory health

Seed
44 employees
AI, Health Care
Compare Trevi Therapeutics, Inc. vs Hyfe

FAQ About Trevi Therapeutics, Inc.

Clinical-stage biopharmaceutical company
Trevi Therapeutics, Inc. was founded in 2011.
Trevi Therapeutics, Inc. is headquartered in New Haven, United States.
Trevi Therapeutics, Inc. operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
Trevi Therapeutics, Inc. has approximately 34 employees.
Trevi Therapeutics, Inc. has completed 7 funding rounds, raising a total of $156.53M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Trevi Therapeutics, Inc. include Melius Pharma, NeRRe Therapeutics Ltd, Hyfe, Exxel Pharma, Insubiq Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Trevi Therapeutics, Inc. and Melius Pharma are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Trevi Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy